Inhibition of the antibody production by acetaminophen independent of liver injury in mice

Katsunori Yamaura, Kohei Ogawa, Taeko Yonekawa, Tomonori Nakamura, Shingo Yano, Koichi Ueno

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The causal relationship between the inhibition of antibody production and liver injury induced by single doses of acetaminophen (APAP) was investigated in mice. The liver injury and antibody production were evaluated using the serum transaminase activity and the number of antibody forming cells against sheep red blood cells (SRBC), respectively. The relevance of APAP hepatotoxicity with inhibiting antibody production was elucidated in fasted and fed mice treated with a single oral administration of APAP. In fasted mice, the oral administration of APAP produced serious liver injury, while it was not the case in the fed mice. As the antibody production was measured under these conditions, APAP significantly depressed the antibody production in fed mice as well as in fasted mice. The rate of B220 positive cells in the splenocytes was significantly decreased by APAP administration in both the fasted and fed mice. Splenocytes proliferative responses following mitogenic stimulation with concanavalin A or lipopolysaccharide were inhibited by APAP. Moreover, APAP added directly to the splenocyte culture also inhibited the in vitro antibody-producing response to SRBC. These findings indicate that the APAP-induced depression of antibody production may not be a secondary response to APAP-hepatitis, but may be a primary response to APAP.

Original languageEnglish
Pages (from-to)201-205
Number of pages5
JournalBiological and Pharmaceutical Bulletin
Volume25
Issue number2
DOIs
Publication statusPublished - 2002 Feb
Externally publishedYes

Fingerprint

Acetaminophen
Antibody Formation
Liver
Wounds and Injuries
Oral Administration
Sheep
Erythrocytes
Concanavalin A
Transaminases
Hepatitis
Lipopolysaccharides

Keywords

  • Acetaminophen
  • Alanine transaminase (ALT)
  • Antibody production
  • Hepatotoxicity
  • Immune suppression
  • Mice

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Inhibition of the antibody production by acetaminophen independent of liver injury in mice. / Yamaura, Katsunori; Ogawa, Kohei; Yonekawa, Taeko; Nakamura, Tomonori; Yano, Shingo; Ueno, Koichi.

In: Biological and Pharmaceutical Bulletin, Vol. 25, No. 2, 02.2002, p. 201-205.

Research output: Contribution to journalArticle

@article{895e3067bd144b8b99dcc663893996ce,
title = "Inhibition of the antibody production by acetaminophen independent of liver injury in mice",
abstract = "The causal relationship between the inhibition of antibody production and liver injury induced by single doses of acetaminophen (APAP) was investigated in mice. The liver injury and antibody production were evaluated using the serum transaminase activity and the number of antibody forming cells against sheep red blood cells (SRBC), respectively. The relevance of APAP hepatotoxicity with inhibiting antibody production was elucidated in fasted and fed mice treated with a single oral administration of APAP. In fasted mice, the oral administration of APAP produced serious liver injury, while it was not the case in the fed mice. As the antibody production was measured under these conditions, APAP significantly depressed the antibody production in fed mice as well as in fasted mice. The rate of B220 positive cells in the splenocytes was significantly decreased by APAP administration in both the fasted and fed mice. Splenocytes proliferative responses following mitogenic stimulation with concanavalin A or lipopolysaccharide were inhibited by APAP. Moreover, APAP added directly to the splenocyte culture also inhibited the in vitro antibody-producing response to SRBC. These findings indicate that the APAP-induced depression of antibody production may not be a secondary response to APAP-hepatitis, but may be a primary response to APAP.",
keywords = "Acetaminophen, Alanine transaminase (ALT), Antibody production, Hepatotoxicity, Immune suppression, Mice",
author = "Katsunori Yamaura and Kohei Ogawa and Taeko Yonekawa and Tomonori Nakamura and Shingo Yano and Koichi Ueno",
year = "2002",
month = "2",
doi = "10.1248/bpb.25.201",
language = "English",
volume = "25",
pages = "201--205",
journal = "Biological and Pharmaceutical Bulletin",
issn = "0918-6158",
publisher = "Pharmaceutical Society of Japan",
number = "2",

}

TY - JOUR

T1 - Inhibition of the antibody production by acetaminophen independent of liver injury in mice

AU - Yamaura, Katsunori

AU - Ogawa, Kohei

AU - Yonekawa, Taeko

AU - Nakamura, Tomonori

AU - Yano, Shingo

AU - Ueno, Koichi

PY - 2002/2

Y1 - 2002/2

N2 - The causal relationship between the inhibition of antibody production and liver injury induced by single doses of acetaminophen (APAP) was investigated in mice. The liver injury and antibody production were evaluated using the serum transaminase activity and the number of antibody forming cells against sheep red blood cells (SRBC), respectively. The relevance of APAP hepatotoxicity with inhibiting antibody production was elucidated in fasted and fed mice treated with a single oral administration of APAP. In fasted mice, the oral administration of APAP produced serious liver injury, while it was not the case in the fed mice. As the antibody production was measured under these conditions, APAP significantly depressed the antibody production in fed mice as well as in fasted mice. The rate of B220 positive cells in the splenocytes was significantly decreased by APAP administration in both the fasted and fed mice. Splenocytes proliferative responses following mitogenic stimulation with concanavalin A or lipopolysaccharide were inhibited by APAP. Moreover, APAP added directly to the splenocyte culture also inhibited the in vitro antibody-producing response to SRBC. These findings indicate that the APAP-induced depression of antibody production may not be a secondary response to APAP-hepatitis, but may be a primary response to APAP.

AB - The causal relationship between the inhibition of antibody production and liver injury induced by single doses of acetaminophen (APAP) was investigated in mice. The liver injury and antibody production were evaluated using the serum transaminase activity and the number of antibody forming cells against sheep red blood cells (SRBC), respectively. The relevance of APAP hepatotoxicity with inhibiting antibody production was elucidated in fasted and fed mice treated with a single oral administration of APAP. In fasted mice, the oral administration of APAP produced serious liver injury, while it was not the case in the fed mice. As the antibody production was measured under these conditions, APAP significantly depressed the antibody production in fed mice as well as in fasted mice. The rate of B220 positive cells in the splenocytes was significantly decreased by APAP administration in both the fasted and fed mice. Splenocytes proliferative responses following mitogenic stimulation with concanavalin A or lipopolysaccharide were inhibited by APAP. Moreover, APAP added directly to the splenocyte culture also inhibited the in vitro antibody-producing response to SRBC. These findings indicate that the APAP-induced depression of antibody production may not be a secondary response to APAP-hepatitis, but may be a primary response to APAP.

KW - Acetaminophen

KW - Alanine transaminase (ALT)

KW - Antibody production

KW - Hepatotoxicity

KW - Immune suppression

KW - Mice

UR - http://www.scopus.com/inward/record.url?scp=0036482240&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036482240&partnerID=8YFLogxK

U2 - 10.1248/bpb.25.201

DO - 10.1248/bpb.25.201

M3 - Article

C2 - 11853166

AN - SCOPUS:0036482240

VL - 25

SP - 201

EP - 205

JO - Biological and Pharmaceutical Bulletin

JF - Biological and Pharmaceutical Bulletin

SN - 0918-6158

IS - 2

ER -